N-Formyl-Met-Leu-Phe-Lys
Need Assistance?
  • US & Canada:
    +
  • UK: +

N-Formyl-Met-Leu-Phe-Lys

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

N-Formyl-Met-Leu-Phe-Lys is a potent and selective agonist of FPR1.

Category
Peptide Inhibitors
Catalog number
BAT-010566
CAS number
67247-11-4
Molecular Formula
C27H43N5O6S
Molecular Weight
565.73
N-Formyl-Met-Leu-Phe-Lys
IUPAC Name
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]hexanoic acid
Synonyms
Fmlfk; For-Met-Leu-Phe-Lys-OH; N-formyl-L-methionyl-L-leucyl-L-phenylalanyl-L-lysine; formyl-MLFK-OH; (5S,8S,11S,14S)-14-(4-aminobutyl)-11-benzyl-5-formamido-8-isobutyl-6,9,12-trioxo-2-thia-7,10,13-triazapentadecan-15-oic acid
Appearance
White to Off-white Lyophilized Solid
Purity
≥95%
Density
1.193±0.06 g/cm3 (Predicted)
Boiling Point
947.3±65.0°C (Predicted)
Sequence
Formyl-Met-Leu-Phe-Lys
Storage
Store at -20°C
Solubility
Soluble in DMSO
InChI
InChI=1S/C27H43N5O6S/c1-18(2)15-22(31-24(34)20(29-17-33)12-14-39-3)25(35)32-23(16-19-9-5-4-6-10-19)26(36)30-21(27(37)38)11-7-8-13-28/h4-6,9-10,17-18,20-23H,7-8,11-16,28H2,1-3H3,(H,29,33)(H,30,36)(H,31,34)(H,32,35)(H,37,38)/t20-,21-,22-,23-/m0/s1
InChI Key
OERILMBTPCSYNG-MLCQCVOFSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC=O
1. Isolation and characterization of a variant HL60 cell line defective in the activation of the NADPH oxidase by phorbol myristate acetate
T Christophe, M Tardif, M J Rabiet, M D Milcent, F Boulay J Immunol . 1998 Dec 15;161(12):6885-95.
Promyelocytic human leukemia HL60 cells can be differentiated into neutrophil-like cells that exhibit an NADPH oxidase activity through direct stimulation of protein kinase C (PKC) with PMA or through formyl peptide receptor activation. We have isolated a variant HL60 clone that exhibited a conditional PMA-induced oxidative response depending on the agent used for the differentiation. While cells differentiated with DMSO responded to either PMA or N-formyl peptide (N-formyl-Met-Leu-Phe-Lys or fMLFK), cells differentiated with dibutyryl-cAMP (Bt2cAMP) responded to fMLFK but very poorly to PMA. However, in Bt2cAMP-differentiated cells, the expression of the different PKC isoforms was similar to that observed in DMSO-differentiated cells. Moreover, PMA was able to induce a normal phosphorylation of the cytosolic factor p47phox and to fully activate extracellular signal-regulated kinases (Erk1/2). Interestingly, Bt2cAMP-differentiated cells exhibited a strong and sustained O2- production when costimulated with PMA and suboptimal concentrations of fMLFK which were, per se, ineffective. This sustained response was only slightly reduced by the conjunction of the mitogen-activated protein (MAP) kinase kinase (MEK) inhibitor PD98059 and wortmannin, a phosphatidylinositol-3 kinase (PI3K) inhibitor. Variant HL60 cells that were stably transfected with a constitutively active form of Rac1 were able, when differentiated with Bt2cAMP, to secrete oxidant following PMA stimulation. Altogether, the results suggest that, in addition to the phosphorylation of p47phox, the activation of NADPH oxidase requires the activation of a Rac protein through a pathway that diverges at a point upstream of MEK and that is independent of the activation of wortmannin sensitive PI3K.
2. Physical coupling of N-formyl peptide chemoattractant receptors to G protein is unaffected by desensitization
K N Klotz, A J Jesaitis Biochem Pharmacol . 1994 Sep 15;48(6):1297-300. doi: 10.1016/0006-2952(94)90168-6.
Desensitization of N-formyl peptide chemoattractant receptors (FPR) in human neutrophils results in association of these receptors to the membrane skeleton. This is thought to be the critical event in the lateral segregation of receptors and guanyl nucleotide-binding proteins (G proteins) within the plane of the plasma membrane resulting in an interruption of the signaling cascade. In this study we probed the interaction of FPR with G protein in human neutrophils that were desensitized to various degrees. Human neutrophils were desensitized using the photoreactive agonist N-formyl-met-leu-phe-lys-N epsilon-[125I]2(p-azidosalicylamino)ethyl-1,3'- dithiopropionate (fMLFK-[125I]ASD). The interaction of FPR with protein was studied via a reconstitution assay and subsequent analysis of FPR-G protein complexes in sucrose density gradients. FPR-G protein complexes were reconstituted with solubilized FPR from partially and fully desensitized neutrophils with increasing concentrations of Gi purified from bovine brain. The respective EC50 values for reconstitution were similar to that determined for FPR from unstimulated neutrophils (Bommakanti RK et al., J Biol Chem 267: 7576-7581, 1992). We conclude, therefore, that the affinity of the interaction of FPR with G protein is not affected by desensitization, consistent with the model of lateral segregation of FPR and G protein as a mechanism of desensitization.
3. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils
K N Klotz, J Gripentrog, K L Krotec, A J Jesaitis J Immunol . 1994 Jan 15;152(2):801-10.
The cytoskeleton and/or membrane skeleton has been implicated in the regulation of N-formyl peptide receptors. The coupling of these chemotactic receptors to the membrane skeleton was investigated in plasma membranes from unstimulated and desensitized human neutrophils using the photoreactive agonist N-formyl-met-leu-phe-lys-N epsilon-[125I]2(p-azidosalicylamido)ethyl-1,3'- dithiopropionate (fMLFK-[125I]ASD). When membranes of unstimulated cells were solubilized in Triton-X 100, a detergent that does not disrupt actin filaments, only 50% of the photoaffinity-labeled receptors were solubilized sedimenting in sucrose density gradients at a rate consistent with previous reports. The remainder were found in the pellet fraction along with the membrane skeletal actin. Solubilization of the membranes in the presence of p-chloromercuriphenylsulfonic acid, elevated concentrations of KCl, or deoxyribonuclease I released receptors in parallel with actin. When membranes from neutrophils, desensitized by incubation with fMLFK-[125I]ASD at 15 degrees C, were solubilized, nearly all receptors were recovered in the pellet fraction. Incubation of cells with the ligand at 4 degrees C inhibited desensitization partially and prevented the conversion of a significant fraction of receptors to the form associated with the membrane skeletal pellet. In these separations the photoaffinity-labeled receptors not sedimenting to the pellet cosedimented with actin. Approximately 25% of these receptors could be immunosedimented with antiactin antibodies suggesting that N-formyl peptide receptors may interact directly with actin. These results are consistent with a regulatory role for the interaction of chemotactic N-formyl peptide receptors with actin of the membrane skeleton.
Online Inquiry
Verification code
Inquiry Basket